RE:Pfizer taps McKinsey veteran Malik as new dealmaking czar
Jun 16, 2021 Mckinsey Virtual meeting : New Approaches to I/O With Innovative Partnership Models"It Takes a Village: New Approaches to I/O with Innovative Partnership Models
"Collaboration among industry stakeholders is essential to discovering and developing emerging I/O approaches – where many see a promise in revolutionizing treatments for all types of cancer.
In 2020, despite the challenges of the COVID-19 pandemic, immuno-oncology assets represented 49% of oncology licensing transactions (out of a total value of $56B, Nature) and 66% of total disclosed deal value (out of a total value of $133B, Nature).
With new partnerships and deals being announced on a near-daily basis, 2021 appears to be staying on trend.."